Microcarriers for cell culture and methods for culturing cells

The microcarrier with a polyvinyl alcohol derivative and peptide coating layer addresses cell aggregate-induced adhesion issues, ensuring efficient and uniform cell culture by preventing clumping and enhancing adhesion, thus maintaining high culture efficiency and safety.

JP7880812B2Active Publication Date: 2026-06-26SEKISUI CHEMICAL CO LTD

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
SEKISUI CHEMICAL CO LTD
Filing Date
2022-02-02
Publication Date
2026-06-26

Smart Images

  • Figure 0007880812000007
    Figure 0007880812000007
  • Figure 0007880812000001
    Figure 0007880812000001
  • Figure 0007880812000002
    Figure 0007880812000002
Patent Text Reader

Abstract

Provided is a microcarrier for cell culture capable of inhibiting adhesion between microcarriers by cell masses. The microcarrier for cell culture according to the present invention comprises base particles and a coating layer covering the outer surface of the base particles, wherein: the coating layer contains a resin that has a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic ester skeleton and a peptide moiety; the average particle size is 300 μm or more; and the CV of the particle size is 10% or less.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] This invention relates to a microcarrier for cell culture. Furthermore, this invention relates to a method for culturing cells using the above-mentioned microcarrier for cell culture. [Background technology]

[0002] In research and development in academic fields, drug discovery, and regenerative medicine, animal cells from humans, mice, rats, pigs, cattle, and monkeys are used. Microcarrier-based cell culture methods are known. Traditionally, extracellular matrix (ECM) has been used as the material for microcarriers.

[0003] Furthermore, as shown in Patent Document 1 below, microcarriers made from synthetic resins are also known.

[0004] Patent Document 1 below discloses a microcarrier for cell culture comprising a polymeric microcarrier base portion formed from a copolymer of a mixture of specific monomers, and a polypeptide conjugated to the microcarrier base portion. In this microcarrier, the equilibrium water content of the microcarrier base portion exceeds 75%. [Prior art documents] [Patent Documents]

[0005] [Patent Document 1] WO2010 / 138702A1 [Overview of the Initiative] [Problems that the invention aims to solve]

[0006] When cells are cultured using conventional microcarriers as described in Patent Document 1, cell aggregates may form between the microcarriers, and the microcarriers may adhere to each other via these formed cell aggregates. In this case, the cell aggregates become clumpy, and the efficiency of cell culture decreases.

[0007] The object of the present invention is to provide a microcarrier for cell culture that can suppress adhesion between microcarriers due to cell aggregates. The object of the present invention is also to provide a method for culturing cells using the above-mentioned microcarrier for cell culture. [Means for solving the problem]

[0008] A broad aspect of the present invention provides a microcarrier for cell culture (hereinafter sometimes referred to as a microcarrier) comprising a base particle and a coating layer covering the outer surface of the base particle, wherein the coating layer contains a resin having a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic acid ester skeleton and a peptide portion, and the average particle diameter is 300 μm or more, and the CV value of the particle diameter is 10% or less.

[0009] In certain aspects of the microcarrier according to the present invention, the water absorption rate is 10% by weight or less.

[0010] In a specific aspect of the microcarriers according to the present invention, the average particle diameter is 1000 μm or less.

[0011] In a particular aspect of the microcarrier according to the present invention, the polyvinyl alcohol derivative skeleton is a polyvinyl acetal skeleton.

[0012] In a specific aspect of the microcarrier according to the present invention, the specific gravity is 1 g / cm³. 3 More than 1.2g / cm 3 The following applies:

[0013] In a particular aspect of the microcarrier according to the present invention, the substrate particles are resin particles.

[0014] In a particular aspect of the microcarrier according to the present invention, the substrate particles include a polymer of monomers having ethylenically unsaturated groups.

[0015] In a specific aspect of the microcarriers according to the present invention, the polymer of the monomer having an ethylenically unsaturated group is an acrylic resin, a divinylbenzene polymer, or a divinylbenzene copolymer.

[0016] In a specific aspect of the microcarriers according to the present invention, the peptide moiety has a cell-adhesive amino acid sequence.

[0017] According to a broad aspect of the present invention, there is provided a method for culturing cells, comprising a step of adhering cells to the above-described microcarriers for cell culture.

Effect of the Invention

[0018] The microcarriers for cell culture according to the present invention include a base material particle and a coating layer covering the outer surface of the base material particle, and the coating layer contains a resin having a polyvinyl alcohol derivative skeleton or a poly(meth)acrylate skeleton and a peptide moiety. In the microcarriers for cell culture according to the present invention, the average particle diameter is 300 μm or more, and the CV value of the particle diameter is 10% or less. In the microcarriers for cell culture according to the present invention, since the above configuration is provided, adhesion between microcarriers due to cell aggregates can be suppressed.

Brief Description of the Drawings

[0019] [Figure 1] FIG. 1 is a cross-sectional view schematically showing a microcarrier for cell culture according to an embodiment of the present invention.

Modes for Carrying Out the Invention

[0020] Hereinafter, the details of the present invention will be described.

[0021] (Microcarriers for Cell Culture) The microcarrier for cell culture according to the present invention (hereinafter sometimes abbreviated as "microcarrier") comprises a base particle and a coating layer covering the outer surface of the base particle, wherein the coating layer contains a resin having a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic acid ester skeleton and a peptide portion. The microcarrier according to the present invention has an average particle diameter of 300 μm or more and a CV value of the particle diameter of 10% or less.

[0022] Since the microcarrier according to the present invention is equipped with the above configuration, adhesion between microcarriers due to cell aggregates can be suppressed.

[0023] Conventionally, microcarriers with a relatively small average particle size (for example, microcarriers with an average particle size of about 100 μm to 200 μm) have been used as microcarriers for cell culture. By using microcarriers with a small average particle size, the specific surface area of ​​the microcarriers can be increased, thereby increasing the area on which cells can adhere. However, with conventional microcarriers with a small average particle size, cell clumps may form between the microcarriers, and the microcarriers may adhere to each other through these formed cell clumps, resulting in a decrease in the efficiency of cell culture.

[0024] In contrast, the microcarriers according to the present invention have a relatively large average particle size and relatively uniform particle size. Furthermore, the microcarriers according to the present invention comprise a base particle and a coating layer containing a specific resin. By adopting the above-described configuration, the microcarriers according to the present invention can suppress adhesion between microcarriers due to cell aggregates. Furthermore, the microcarriers according to the present invention can improve the adhesion between microcarriers and cells. Moreover, the microcarriers according to the present invention can form cell aggregates of uniform thickness on the surface of each microcarrier, and can increase the surface area covered by the cell aggregates on each microcarrier. Therefore, the microcarriers according to the present invention can maintain a high cell culture efficiency.

[0025] Furthermore, since the microcarriers according to the present invention do not require the use of natural polymer materials such as extracellular matrix (ECM) as materials, they are inexpensive, have low lot-to-lot variability, and offer excellent safety.

[0026] The average particle size of the above microcarriers is 300 μm or larger. If the average particle size of the above microcarriers is less than 300 μm, cell clumps will form between the microcarriers, and the microcarriers will adhere to each other via these cell clumps.

[0027] The average particle diameter of the above microcarriers is preferably 350 μm or more, more preferably 400 μm or more, even more preferably 500 μm or more, particularly preferably 600 μm or more, preferably 1500 μm or less, more preferably 1000 μm or less, even more preferably 800 μm or less, and particularly preferably 700 μm or less. The average particle diameter of the above microcarriers is preferably 350 μm or more and 1500 μm or less, more preferably 400 μm or more and 1000 μm or less, even more preferably 500 μm or more and 800 μm or less, and particularly preferably 600 μm or more and 700 μm or less. When the above average particle diameter is above the above lower limit, the effects of the present invention can be exhibited more effectively. When the above average particle diameter is below the above upper limit, cell aggregates can be formed with a more uniform thickness on the surface of each microcarrier. In addition, when the above average particle diameter is below the above upper limit, the area on which cells can adhere can be further increased.

[0028] The particle size of the above-mentioned microcarrier refers to the diameter if the microcarrier is spherical, and if the microcarrier has a shape other than a perfect sphere, it refers to the diameter assuming it is a perfect sphere of a volume equivalent to that shape.

[0029] The average particle diameter of the above microcarriers is preferably the number-average particle diameter. The average particle diameter of the above microcarriers can be determined by observing 50 arbitrary microcarriers with an electron microscope or optical microscope and calculating the average value of the particle diameter of each microcarrier, or by using a particle size distribution analyzer. In observation with an electron microscope or optical microscope, the particle diameter of a single microcarrier is determined as the particle diameter at the equivalent diameter of a circle. In observation with an electron microscope or optical microscope, the average particle diameter at the equivalent diameter of a circle of any 50 microcarriers is approximately equal to the average particle diameter at the equivalent diameter of a sphere. In a particle size distribution analyzer, the particle diameter of a single microcarrier is determined as the particle diameter at the equivalent diameter of a sphere. It is preferable to calculate the average particle diameter of the above microcarriers using a particle size distribution analyzer.

[0030] From the viewpoint of achieving the effects of the present invention, the coefficient of variation (CV value) of the particle size of the above microcarriers is 10% or less.

[0031] The coefficient of variation (CV value) of the particle size of the above microcarriers is preferably 8% or less, more preferably 5% or less, and even more preferably 3% or less. When the coefficient of variation (CV value) is below the above upper limit, the effects of the present invention can be exhibited even more effectively. The coefficient of variation (CV value) of the particle size of the above microcarriers may be 0% or more, 0.1% or more, or 1% or more. The coefficient of variation (CV value) of the particle size of the above microcarriers may be 0% to 10%, 0.1% to 8%, 0.1% to 5%, or 1% to 3%.

[0032] The coefficient of variation (CV value) of the particle size of the above microcarriers is calculated as follows.

[0033] CV value (%) = (ρ / Dn) × 100 ρ: Standard deviation of the particle size of the microcarrier Dn: Average particle size of microcarriers

[0034] Methods for reducing the coefficient of variation (CV value) of the particle size of the above-mentioned microcarriers include dry classification and wet classification.

[0035] The shape of the microcarrier described above is not particularly limited. The shape of the microcarrier may be spherical, or it may be a shape other than spherical, such as a flattened shape. Note that the spherical shape is not limited to a perfect sphere, but also includes a nearly spherical shape, for example, a shape with an aspect ratio (major axis / minor axis) of 1.5 or less.

[0036] The specific gravity of the above microcarriers is preferably 1 g / cm³. 3 More preferably 1.05 g / cm³ 3 Preferably 1.2 g / cm³ 3 More preferably, 1.15 g / cm³ 3 The following applies: If the specific gravity is above the lower limit, the microcarriers will settle appropriately, improving the recovery efficiency. If the specific gravity is below the upper limit, the rotational performance of the agitator blades can be improved.

[0037] The specific gravity of the above microcarriers is measured using a hydrometer.

[0038] The water absorption rate of the above microcarrier is preferably 10% by weight or less, more preferably 5% by weight or less, and even more preferably 1% by weight or less. When the water absorption rate is below the above upper limit, the surface state of the microcarrier is less likely to change during cell adhesion, thus reducing the variability in the initial colonization rate after cell seeding. Furthermore, when the water absorption rate is below the above upper limit, cells are less likely to detach from the microcarrier in the culture medium. The lower limit of the water absorption rate of the above microcarrier is not particularly limited. The water absorption rate of the above microcarrier may be 0% by weight or more, or 0.001% by weight or more.

[0039] The water absorption rate of the above microcarriers can be measured as follows.

[0040] Prepare microcarriers by drying them in a 100°C oven for 8 hours. Leave 100.0 mg of these microcarriers for 24 hours in an environment with a temperature of 37°C and a relative humidity of 95% RH. Measure the weight of the microcarriers after this period. Calculate the water absorption rate of the microcarriers using the following formula.

[0041] Water absorption rate (weight %)=(W2-W1) / W1×100 W1: Weight of microcarriers before storage (mg) W2: Weight of microcarriers after standing (mg)

[0042] One method for reducing the water absorption rate of the above-mentioned microcarriers is to create a coating layer using a highly hydrophobic material.

[0043] The present invention will be described in detail below with reference to the drawings.

[0044] Figure 1 is a schematic cross-sectional view showing a microcarrier for cell culture according to one embodiment of the present invention.

[0045] The cell culture microcarrier 1 shown in Figure 1 comprises a base particle 2 and a coating layer 3 that covers the outer surface of the base particle 2. The coating layer 3 is positioned on the surface of the base particle 2 and is in contact with the surface of the base particle 2. The coating layer 3 covers the entire outer surface of the base particle 2. The coating layer 3 contains a resin having a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic acid ester skeleton and a peptide portion.

[0046] Further details about microcarriers are described below.

[0047] In this specification, "(meth)acrylate" means either or both "acrylate" and "methacrylate," and "(meth)acrylic" means either or both "acrylic" and "methacrylic."

[0048] (base material particles) The material of the above-mentioned base particles is not particularly limited. The material of the above-mentioned base particles is preferably an organic material. The base particles preferably contain a resin. The base particles are preferably resin particles because they are easy to manufacture. The material of the above-mentioned base particles may be one type only, or two or more types may be used in combination. The resin may be one type only, or two or more types may be used in combination.

[0049] Examples of the above-mentioned organic materials (resins) include polyolefin resins, acrylic resins, polycarbonates, polyamides, phenol formaldehyde resins, melamine formaldehyde resins, benzoguanamine formaldehyde resins, urea formaldehyde resins, phenolic resins, melamine resins, benzoguanamine resins, urea resins, epoxy resins, unsaturated polyester resins, saturated polyester resins, polyethylene terephthalate, polysulfones, polyphenylene oxides, polyacetals, polyimides, polyamide-imides, polyetheretherketones, polyethersulfones, divinylbenzene polymers, and divinylbenzene copolymers.

[0050] Examples of the polyolefin resins mentioned above include polyethylene, polypropylene, polystyrene, polyvinyl chloride, polyvinylidene chloride, polyisobutylene, and polybutadiene.

[0051] Examples of the above-mentioned acrylic resin include polymers of monomers such as (meth)acrylic acid, methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, t-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, octyl (meth)acrylate, isopropyl (meth)acrylate, and propyl (meth)acrylate. The above-mentioned acrylic resin may be a homopolymer of the above-mentioned monomers, a copolymer of the above-mentioned monomers, or a copolymer of the above-mentioned monomers with other monomers. Examples of the above-mentioned acrylic resin include polymethyl methacrylate and polymethyl acrylate.

[0052] The material of the above-mentioned base particles is preferably a polymer obtained by polymerizing one or more polymerizable monomers having ethylenically unsaturated groups. The above-mentioned resin is preferably a polymer of monomers having ethylenically unsaturated groups. The above-mentioned base particles preferably contain a polymer of monomers having ethylenically unsaturated groups. In this case, the specific gravity of the base particles can be well adjusted, and as a result, the specific gravity of the microcarriers can be adjusted to a suitable range.

[0053] Examples of polymers of monomers having the above-mentioned ethylenically unsaturated group include acrylic resins, divinylbenzene polymers, and divinylbenzene copolymers. The above-mentioned monomers having the ethylenically unsaturated group may be used individually or in combination of two or more.

[0054] The polymer of the monomer having the ethylenically unsaturated group described above is preferably an acrylic resin, a divinylbenzene polymer, or a divinylbenzene copolymer. In this case, the specific gravity of the base particles can be well adjusted, and as a result, the specific gravity of the microcarriers can be adjusted to a suitable range.

[0055] When the above-mentioned base particles contain a polymer of a monomer having an ethylenically unsaturated group, it is preferable that the polymer of the monomer having an ethylenically unsaturated group has a crosslinked structure. In this case, the specific gravity of the base particles can be well adjusted, and as a result, the specific gravity of the microcarriers can be adjusted to a suitable range.

[0056] Examples of methods for forming the above-mentioned crosslinked structure include: (1) a method of polymerizing a polymerizable component containing a monomer having two or more ethylenically unsaturated groups; and (2) a method of forming a crosslinked structure by reacting a polymer of monomers having ethylenically unsaturated groups with a crosslinking agent.

[0057] In the method described in (1) above, examples of monomers having two or more ethylenically unsaturated groups include divinylbenzene, polyfunctional (meth)acrylate, triallyl(iso)cyanurate, triallyl trimellitate, diallyl phthalate, and diallyl acrylamide. Only one of the monomers having two or more ethylenically unsaturated groups may be used, or two or more may be used in combination.

[0058] Furthermore, in the method of (1) described above, the polymerizable component may also include other monomers having an ethylenically unsaturated group. Examples of other monomers having an ethylenically unsaturated group include styrene, monofunctional (meth)acrylate, (meth)acrylic acid, acrylonitrile, vinyl chloride, and the like. Only one of the other monomers having an ethylenically unsaturated group may be used, or two or more may be used in combination.

[0059] Examples of polymers obtained by the method described in (1) above include copolymers of divinylbenzene and styrene, and copolymers of polyfunctional (meth)acrylate and monofunctional (meth)acrylate.

[0060] One example of the method described in (2) above is a polymerizable component containing a monomer having an ethylenically unsaturated group and a functional group containing active hydrogen in its molecule, which is polymerized to obtain a polymer, and then a crosslinking agent is used to crosslink the polymers.

[0061] Examples of functional groups containing the active hydrogen mentioned above include hydroxyl groups, carboxyl groups, amino groups, and phenol groups. Examples of monomers having an ethylenically unsaturated group and a functional group containing active hydrogen in their molecule include hydroxyl group-containing (meth)acrylate, (meth)acrylic acid, and amino group-containing (meth)acrylate. Only one of the above monomers having an ethylenically unsaturated group and a functional group containing active hydrogen in their molecule may be used, or two or more may be used in combination.

[0062] The above crosslinking agent is not particularly limited as long as it can react with the functional group containing the active hydrogen, and examples include polyfunctional isocyanate compounds and polyfunctional epoxy compounds. The above crosslinking agent may be used alone or in combination of two or more.

[0063] The above-mentioned substrate particles can be obtained, for example, by polymerizing the monomer having the above-mentioned ethylenically unsaturated group. The polymerization method is not particularly limited and includes known methods such as radical polymerization, ionic polymerization, polycondensation (condensation polymerization, condensation polymerization), addition condensation, living polymerization, and living radical polymerization. Another polymerization method is suspension polymerization in the presence of a radical polymerization initiator.

[0064] The above-mentioned base material particles preferably contain a divinylbenzene polymer, a divinylbenzene copolymer, a polystyrene resin, or an acrylic resin, and more preferably contain a divinylbenzene polymer, a divinylbenzene copolymer, or an acrylic resin. The above-mentioned base material particles preferably consist of divinylbenzene polymer particles, divinylbenzene copolymer particles, a polystyrene resin particle, or an acrylic resin particle, and more preferably consist of divinylbenzene polymer particles, divinylbenzene copolymer particles, or an acrylic resin particle. In this case, the specific gravity of the microcarriers can be suitably controlled.

[0065] The resin content in 100% by weight of the above base material particles is preferably 80% by weight or more, more preferably 90% by weight or more, even more preferably 95% by weight or more, still more preferably 97% by weight or more, even more preferably 99% by weight or more, and most preferably 100% by weight (total amount). However, the resin content in 100% by weight of the above base material particles may be 100% by weight or less, or less than 100% by weight.

[0066] The average particle diameter of the above-mentioned base material particles is preferably 300 μm or more, more preferably 350 μm or more, even more preferably 400 μm or more, still more preferably 500 μm or more, particularly preferably 600 μm or more, preferably 1500 μm or less, more preferably 1000 μm or less, still more preferably 800 μm or less, and particularly preferably 700 μm or less. The average particle diameter of the above-mentioned base material particles is preferably 300 μm or more and 1500 μm or less, more preferably 350 μm or more and 1000 μm or less, even more preferably 400 μm or more and 1000 μm or less, still more preferably 500 μm or more and 800 μm or less, and particularly preferably 600 μm or more and 700 μm or less. When the above-mentioned average particle diameter is above the lower limit, the effects of the present invention can be exhibited more effectively. When the above-mentioned average particle diameter is below the upper limit, cell aggregates can be formed on the surface of each microcarrier with a more uniform thickness.

[0067] The particle diameter of the above-mentioned base material particles refers to the diameter if the base material particles are spherical, and if the base material particles have a shape other than a perfect sphere, it refers to the diameter assuming they are spherical to the extent of their volume.

[0068] The average particle diameter of the above-mentioned substrate particles is preferably the number-average particle diameter. The average particle diameter of the above-mentioned substrate particles can be determined by observing 50 arbitrary substrate particles with an electron microscope or optical microscope and calculating the average value of the particle diameter of each substrate particle, or by using a particle size distribution analyzer. In observation with an electron microscope or optical microscope, the particle diameter of a single substrate particle is determined as the particle diameter at the equivalent diameter of a circle. In observation with an electron microscope or optical microscope, the average particle diameter at the equivalent diameter of a circle of any 50 substrate particles is approximately equal to the average particle diameter at the equivalent diameter of a sphere. In a particle size distribution analyzer, the particle diameter of a single substrate particle is determined as the particle diameter at the equivalent diameter of a sphere. It is preferable to calculate the average particle diameter of the above-mentioned substrate particles using a particle size distribution analyzer.

[0069] (covering layer) The above microcarrier comprises a base particle and a coating layer that covers the outer surface of the base particle. The coating layer contains a resin (hereinafter sometimes referred to as "resin X") having a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic acid ester skeleton and a peptide portion. Resin X has a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic acid ester skeleton and a peptide portion. Resin X is a synthetic resin. The coating layer contains resin X. Only one type of resin X may be used, or two or more types may be used in combination.

[0070] The resin X may have a polyvinyl alcohol derivative skeleton and a peptide portion, or a poly(meth)acrylic acid ester skeleton and a peptide portion, or a polyvinyl alcohol derivative skeleton, a poly(meth)acrylic acid ester skeleton and a peptide portion.

[0071] In the resin X having the polyvinyl alcohol derivative skeleton described above, it is preferable that the polyvinyl alcohol derivative skeleton and the peptide portion are linked via a linker portion. Therefore, it is preferable that the resin X having the polyvinyl alcohol derivative skeleton comprises a polyvinyl alcohol derivative skeleton, a peptide portion, and a linker portion.

[0072] In the resin X having the poly(meth)acrylic acid ester skeleton described above, the poly(meth)acrylic acid ester skeleton and the peptide portion may be bonded via a linker portion, or they may be directly bonded without a linker portion. The resin X having the poly(meth)acrylic acid ester skeleton described above may also have a poly(meth)acrylic acid ester skeleton, a peptide portion, and a linker portion.

[0073] <Polyvinyl alcohol derivative skeleton> The polyvinyl alcohol derivative skeleton described above is a skeletal portion derived from a polyvinyl alcohol derivative. The polyvinyl alcohol derivative is a compound derived from polyvinyl alcohol. From the viewpoint of further improving the adhesion between microcarriers and cells, the polyvinyl alcohol derivative is preferably a polyvinyl acetal resin, and the polyvinyl alcohol derivative skeleton is preferably a polyvinyl acetal skeleton. That is, the resin X preferably has a polyvinyl acetal skeleton and the peptide portion described above. Only one of the polyvinyl alcohol derivative and the polyvinyl acetal resin may be used, or two or more may be used in combination.

[0074] The polyvinyl alcohol derivative skeleton and the polyvinyl acetal skeleton preferably have an acetal group, a hydroxyl group, and an acetyl group in their side chains. However, the polyvinyl alcohol derivative skeleton and the polyvinyl acetal skeleton may not have acetyl groups, for example. For example, all of the acetyl groups of the polyvinyl alcohol derivative skeleton and the polyvinyl acetal skeleton may be bonded to the linker, so the polyvinyl alcohol derivative skeleton and the polyvinyl acetal skeleton may not have acetyl groups.

[0075] Polyvinyl acetal resin can be synthesized by acetalizing polyvinyl alcohol with an aldehyde.

[0076] The aldehyde used in the acetalization of polyvinyl alcohol is not particularly limited. Examples of the aldehyde include aldehydes having 1 to 10 carbon atoms. The aldehyde may or may not have a linear aliphatic group, a cyclic aliphatic group, or an aromatic group. The aldehyde may be a linear aldehyde or a cyclic aldehyde. Only one aldehyde may be used, or two or more may be used in combination.

[0077] From the viewpoint of further enhancing the adhesion between microcarriers and cells, the aldehyde is preferably formaldehyde, acetaldehyde, propionaldehyde, butyraldehyde, or pentanal, and more preferably butyraldehyde. Therefore, the polyvinyl acetal resin is more preferably polyvinyl butyral resin, the polyvinyl acetal skeleton is more preferably polyvinyl butyral skeleton, and the resin X is more preferably having a polyvinyl butyral skeleton.

[0078] In the above resin X, the degree of acetalization of the polyvinyl alcohol derivative skeleton and the polyvinyl acetal skeleton (the degree of butyralization in the case of polyvinyl butyral resin) is preferably 40 mol% or more, more preferably 50 mol% or more, more preferably 90 mol% or less, and more preferably 85 mol% or less. If the degree of acetalization is above the lower limit, the cell adhesion can be further improved, and cells can proliferate efficiently. If the degree of acetalization is below the upper limit, the solubility in solvents can be improved.

[0079] In the above resin X, the content of hydroxyl groups (amount of hydroxyl groups) of the polyvinyl alcohol derivative skeleton and the polyvinyl acetal skeleton is preferably 15 mol% or more, more preferably 20 mol% or more, preferably 45 mol% or less, more preferably 30 mol% or less, and even more preferably 25 mol% or less.

[0080] In the above resin X, the degree of acetylation (amount of acetyl groups) of the polyvinyl alcohol derivative skeleton and the polyvinyl acetal skeleton is preferably 1 mol% or more, more preferably 2 mol% or more, more preferably 5 mol% or less, and more preferably 4 mol% or less. When the degree of acetylation is above the lower limit and below the upper limit, the reaction efficiency between the polyvinyl acetal resin and the linker can be increased.

[0081] The degree of acetalization, degree of acetylation, and hydroxyl groups of the above polyvinyl alcohol derivative skeleton and the above polyvinyl acetal skeleton are as follows: 1It can be measured using 1H-NMR (nuclear magnetic resonance spectroscopy).

[0082] <Poly(meth)acrylic acid ester skeleton> The above poly(meth)acrylic acid ester skeleton is a skeleton portion derived from poly(meth)acrylic acid ester. The above poly(meth)acrylic acid ester is obtained by polymerization of (meth)acrylic acid ester. The above poly(meth)acrylic acid ester skeleton has a skeleton derived from (meth)acrylic acid ester. The above poly(meth)acrylic acid ester may be used alone, or two or more may be used in combination.

[0083] Examples of the above (meth)acrylic acid esters include alkyl (meth)acrylates, cyclic alkyl (meth)acrylates, aryl (meth)acrylates, polyethylene glycol (meth)acrylates, phosphorylcholine (meth)acrylates, etc. The above (meth)acrylic acid esters may be used individually or in combination of two or more.

[0084] Examples of the alkyl (meth)acrylates mentioned above include methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, t-butyl (meth)acrylate, n-octyl (meth)acrylate, isooctyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, nonyl (meth)acrylate, isononyl (meth)acrylate, decyl (meth)acrylate, isodecyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate, and isotetradecyl (meth)acrylate.

[0085] The above alkyl (meth)acrylate may be substituted with substituents such as alkoxy groups having 1 to 3 carbon atoms and tetrahydrofurfuryl groups. Examples of such alkyl (meth)acrylates include methoxyethyl acrylate and tetrahydrofurfuryl acrylate.

[0086] Examples of the above-mentioned cyclic alkyl (meth)acrylates include cyclohexyl (meth)acrylate and isobornyl (meth)acrylate.

[0087] Examples of the above-mentioned aryl (meth)acrylates include phenyl (meth)acrylate and benzyl (meth)acrylate.

[0088] Examples of the above-mentioned (meth)acrylic polyethylene glycols include methoxy-polyethylene glycol (meth)acrylate, ethoxy-polyethylene glycol (meth)acrylate, hydroxy-polyethylene glycol (meth)acrylate, methoxy-diethylene glycol (meth)acrylate, ethoxy-diethylene glycol (meth)acrylate, hydroxy-diethylene glycol (meth)acrylate, methoxy-triethylene glycol (meth)acrylate, ethoxy-triethylene glycol (meth)acrylate, and hydroxy-triethylene glycol (meth)acrylate.

[0089] Examples of the above-mentioned (meth)acrylic acid phosphorylcholine include 2-(meth)acryloyloxyethyl phosphorylcholine.

[0090] The resin X having the poly(meth)acrylic acid ester skeleton described above preferably has structural units derived from a (meth)acrylate compound (A) represented by the following formula (A1) or (A2). The poly(meth)acrylic acid ester skeleton preferably has structural units derived from a (meth)acrylate compound (A) represented by the following formula (A1) or (A2). This makes the hydrophobicity of the coating layer greater, and therefore the water absorption rate of the microcarriers even smaller. As a result, the variation in the initial establishment rate after cell seeding can be reduced, and cells become less likely to detach from the microcarriers in the culture medium. The (meth)acrylate compound (A) described above may contain a (meth)acrylate compound represented by the following formula (A1), or it may contain a (meth)acrylate compound represented by the following formula (A2), or it may contain both a (meth)acrylate compound represented by the following formula (A1) and a (meth)acrylate compound represented by the following formula (A2). When the above (meth)acrylate compound (A) includes both the (meth)acrylate compound represented by the following formula (A1) and the (meth)acrylate compound represented by the following formula (A2), R in the following formula (A1) and R in the following formula (A2) may be the same or different. The above (meth)acrylate compound (A) may be used alone or in combination of two or more types. Furthermore, the (meth)acrylate compound represented by the following formula (A1) and the (meth)acrylate compound represented by the following formula (A2) may each be used alone or in combination of two or more types.

[0091] [ka]

[0092] In the above formula (A1), R represents a hydrocarbon group having 2 to 18 carbon atoms.

[0093] [ka]

[0094] In the above formula (A2), R represents a hydrocarbon group having 2 to 18 carbon atoms.

[0095] R in formula (A1) and R in formula (A2) above may each be an aliphatic hydrocarbon group or an aromatic hydrocarbon group. From the viewpoint of improving the solubility of the resin X having the poly(meth)acrylic acid skeleton, it is preferable that R in formula (A1) and R in formula (A2) above are aliphatic hydrocarbon groups. The aliphatic hydrocarbon group may be linear, branched, have a double bond, or not have a double bond. R in formula (A1) and R in formula (A2) above may each be an alkyl group or an alkylene group.

[0096] The number of carbon atoms in R in formula (A1) and formula (A2) is preferably 4 or more, more preferably 6 or more, even more preferably 8 or more, particularly preferably 10 or more, preferably 16 or less, more preferably 14 or less, and most preferably 12. When the number of carbon atoms is above the lower limit, the hydrophobicity of the resin X can be further increased, and therefore the water absorption rate of the microcarriers can be further reduced. When the number of carbon atoms is below the upper limit, the coatability when placing the coating layer material on the surface of the substrate particles can be improved. In particular, when the number of carbon atoms is 12, the water absorption rate of the microcarriers can be reduced even further, and the coatability can be further improved.

[0097] The alkyl (meth)acrylate ester mentioned above is preferably the (meth)acrylate compound (A) mentioned above.

[0098] The resin X having the poly(meth)acrylic acid ester skeleton described above may also have a skeleton derived from monomers other than (meth)acrylic acid esters.

[0099] Examples of monomers other than the (meth)acrylic acid esters mentioned above include (meth)acrylamides and vinyl compounds. Only one of these monomers may be used, or two or more may be used in combination.

[0100] Examples of the above-mentioned (meth)acrylamides include (meth)acrylamide, N-isopropyl(meth)acrylamide, N-tert-butyl(meth)acrylamide, N,N'-dimethyl(meth)acrylamide, (3-(meth)acrylamidopropyl)trimethylammonium chloride, 4-(meth)acryloylmorpholine, 3-(meth)acryloyl-2-oxazolidinone, N-[3-(dimethylamino)propyl](meth)acrylamide, N-(2-hydroxyethyl)(meth)acrylamide, N-methylol(meth)acrylamide, and 6-(meth)acrylamidohexanoic acid.

[0101] Examples of the vinyl compounds mentioned above include ethylene, allylamine, vinylpyrrolidone, maleic anhydride, maleimide, itaconic acid, (meth)acrylic acid, and vinylamine.

[0102] <Peptide Division> The peptide portion described above is a structural part derived from a peptide. The peptide portion has an amino acid sequence. The peptide constituting the peptide portion may be an oligopeptide or a polypeptide. Only one type of peptide may be used, or two or more types may be used in combination.

[0103] The number of amino acid residues in the peptide portion is preferably 3 or more, more preferably 4 or more, even more preferably 5 or more, preferably 10 or fewer, more preferably 8 or fewer, and even more preferably 6 or fewer. When the number of amino acid residues is above the lower limit and below the upper limit, adhesion to cells after seeding can be further enhanced, and the cell proliferation rate can be further enhanced. However, the number of amino acid residues in the peptide portion may exceed 10 or exceed 15.

[0104] The peptide portion described above preferably has a cell-adherent amino acid sequence. A cell-adherent amino acid sequence refers to an amino acid sequence whose cell-adherent activity has been confirmed by phage display, Sepharose bead method, or plate-coating method. For example, the phage display method described in "The Journal of Cell Biology, Volume 130, Number 5, September 1995 1189-1196" can be used. For example, the Sepharose bead method described in "Proteins, Nucleic Acids, Enzymes Vol. 45 No. 15 (2000) 2477" can be used. For example, the plate-coating method described in "Proteins, Nucleic Acids, Enzymes Vol. 45 No. 15 (2000) 2477" can be used.

[0105] Examples of the above-mentioned cell-adhering amino acid sequences include RGD sequence (Arg-Gly-Asp), YIGSR sequence (Tyr-Ile-Gly-Ser-Arg), PDSGR sequence (Pro-Asp-Ser-Gly-Arg), HAV sequence (His-Ala-Val), ADT sequence (Ala-Asp-Thr), QAV sequence (Gln-Ala-Val), LDV sequence (Leu-Asp-Val), IDS sequence (Ile-Asp-Ser), REDV sequence (Arg-Glu-Asp-Val), IDAPS sequence (Ile-Asp-Ala-Pro-Ser), KQAGDV sequence (Lys-Gln-Ala-Gly-Asp-Val), and TDE sequence (Thr-Asp-Glu). Furthermore, examples of the above-mentioned cell-adherent amino acid sequences include those described in "Pathophysiology, Vol. 9, No. 7, pp. 527-535, 1990" and "Osaka Prefectural Maternal and Child Health Center Journal, Vol. 8, No. 1, pp. 58-66, 1992." The above-mentioned peptide portion may have only one of the above-mentioned cell-adherent amino acid sequences, or it may have two or more.

[0106] The above-mentioned cell-adherent amino acid sequence preferably has at least one of the above-mentioned cell-adherent amino acid sequences, more preferably has at least an RGD sequence, a YIGSR sequence, or a PDSGR sequence, and even more preferably has at least an RGD sequence represented by the following formula (1). In this case, adhesion to cells after seeding can be further enhanced, and the cell proliferation rate can be further increased.

[0107] Arg-Gly-Asp-X...Formula (1)

[0108] In the above formula (1), X represents Gly, Ala, Val, Ser, Thr, Phe, Met, Pro, or Asn.

[0109] The peptide portion may be linear or may have a cyclic peptide skeleton. From the viewpoint of further enhancing cell proliferation, it is preferable that the peptide portion has a cyclic peptide skeleton. The cyclic peptide skeleton is a cyclic skeleton composed of multiple amino acids. From the viewpoint of more effectively exhibiting the effects of the present invention, it is preferable that the cyclic peptide skeleton is composed of 4 or more amino acids, more preferably of 5 or more amino acids, and preferably of 10 or fewer amino acids.

[0110] In the above resin X, the content of the peptide portion is preferably 0.1 mol% or more, more preferably 1 mol% or more, even more preferably 5 mol% or more, particularly preferably 10 mol% or more, preferably 60 mol% or less, more preferably 50 mol% or less, even more preferably 35 mol% or less, and particularly preferably 25 mol% or less. If the content of the peptide portion is above the lower limit, the adhesion to cells after seeding can be further enhanced, and the cell proliferation rate can be further enhanced. Also, if the content of the peptide portion is below the upper limit, manufacturing costs can be reduced. Note that the content of the peptide portion (mol%) is the amount of substance of the peptide portion relative to the sum of the amounts of substance of each structural unit constituting the resin X.

[0111] The content of the peptide portion can be measured, for example, by NMR, FT-IR, or LC-MS.

[0112] <Linker section> The linker portion described above is a structural part derived from the linker. The linker portion is usually located between the polyvinyl alcohol derivative skeleton or the poly(meth)acrylic acid ester skeleton and the peptide portion. The polyvinyl alcohol derivative skeleton or the poly(meth)acrylic acid ester skeleton and the peptide portion are linked via the linker portion. The linker portion is formed by a linker (crosslinking agent). Only one type of linker may be used, or two or more types may be used in combination.

[0113] The linker is preferably a compound having a functional group capable of binding to the peptide, and more preferably a compound having a functional group capable of condensing with the carboxyl group or amino group of the peptide.

[0114] Functional groups that can condense with the carboxyl group or amino group of the above peptide include carboxyl groups, thiol groups, amino groups, hydroxyl groups, and cyano groups.

[0115] From the viewpoint of reacting well with peptides, the linker is preferably a compound having a carboxyl group or an amino group, and more preferably a compound having a carboxyl group.

[0116] When obtaining a resin X having a polyvinyl alcohol derivative skeleton, examples of linkers having carboxyl groups include (meth)acrylic acid and carboxyl group-containing acrylamide. By using a polymerizable unsaturated carboxylic acid (carboxylic acid monomer) as the linker having carboxyl groups, the carboxylic acid monomer can be polymerized by graft polymerization when the linker is introduced, thereby increasing the number of carboxyl groups that can react with the peptide.

[0117] From the viewpoint of effectively bonding the polyvinyl alcohol derivative and the peptide, the linker is preferably (meth)acrylic acid, and more preferably acrylic acid.

[0118] When obtaining a resin X having a poly(meth)acrylic acid ester skeleton, it is preferable that the linker has a functional group capable of bonding to the (meth)acrylic acid ester. Examples of functional groups capable of bonding to the (meth)acrylic acid ester include vinyl groups, (meth)acryloyl groups, and allyl groups. It is more preferable that the linker has a (meth)acryloyl group as a functional group capable of bonding to the (meth)acrylic acid ester, and is preferably a compound having a carboxyl group or an amino group and a (meth)acryloyl group.

[0119] Examples of linkers used to obtain a resin X having a poly(meth)acrylic acid ester skeleton include (meth)acrylic acid, itaconic acid, and acrylamide.

[0120] From the viewpoint of effectively bonding poly(meth)acrylic acid esters and peptides, the linker is preferably (meth)acrylic acid or itaconic acid, and more preferably (meth)acrylic acid.

[0121] <Further details about the coating layer> The weight-average molecular weight of the resin X is preferably 10,000 or more, more preferably 50,000 or more, more preferably 1,200,000 or less, and more preferably 600,000 or less. When the weight-average molecular weight is above the lower limit and below the upper limit, the effects of the present invention can be exhibited even more effectively. When the weight-average molecular weight is below the upper limit, the spreadability of cells during cell culture can be increased even more effectively.

[0122] The weight-average molecular weight of the resin X having the polyvinyl alcohol derivative skeleton is preferably 10,000 or more, more preferably 50,000 or more, more preferably 1,200,000 or less, and more preferably 600,000 or less. When the weight-average molecular weight is above the lower limit and below the upper limit, the effects of the present invention can be exhibited even more effectively. When the weight-average molecular weight is below the upper limit, the spreadability of cells during cell culture can be increased even more effectively.

[0123] The weight-average molecular weight of the resin X having the poly(meth)acrylic acid ester skeleton is preferably 10,000 or more, more preferably 50,000 or more, more preferably 1,200,000 or less, and more preferably 600,000 or less. When the weight-average molecular weight is above the lower limit and below the upper limit, the effects of the present invention can be exhibited even more effectively. When the weight-average molecular weight is below the upper limit, the spreadability of cells during cell culture can be increased even more effectively.

[0124] The weight-average molecular weight of the above resin X can be measured, for example, by the following method. Dissolve the above resin X in tetrahydrofuran (THF) to prepare a 0.2 wt% solution of resin X. Next, evaluate it using a gel permeation chromatography (GPC) analyzer (APC system, Waters) under the following measurement conditions.

[0125] Column: HSPgel HR MB-M 6.0×150mm Flow rate: 0.5mL / min Column temperature: 40℃ Injection volume: 10μL Detectors: RI, PDA Standard sample: Polystyrene

[0126] The coating layer may contain only the resin X. The coating layer may also contain components other than the resin X. Examples of components other than the resin X include resins other than resin X. Examples of components other than the resin X include polyvinyl alcohol derivatives such as polyvinyl acetal resin, poly(meth)acrylic acid esters, polyolefin resins, polyether resins, polyvinyl alcohol resins, polyesters, epoxy resins, polyamide resins, polyimide resins, polyurethane resins, polycarbonate resins, cellulose, and polypeptides. Only one of the components other than the resin X may be used, or two or more may be used in combination.

[0127] The coating layer may consist only of a layer containing resin X. The coating layer may also consist of a layer that does not contain resin X and a layer that contains resin X. When the coating layer consists of a layer that does not contain resin X and a layer that contains resin X, it is preferable that the layer that does not contain resin X is located on the substrate particle side and the layer that contains resin X is located on the outside of the layer that does not contain resin X. In this case, the adhesion between the microcarrier and the cells can be further enhanced.

[0128] The resin X is preferably present at least on the outer surface of the microcarrier. The outermost layer of the microcarrier is preferably a layer containing the resin X. In this case, the adhesion between the microcarrier and the cell can be further enhanced.

[0129] In a 100% by weight layer containing the above-mentioned resin X, the content of resin X is preferably 90% by weight or more, more preferably 95% by weight or more, even more preferably 97.5% by weight or more, particularly preferably 99% by weight or more, and most preferably 100% by weight (total amount). When the content of resin X is above the lower limit, the effects of the present invention can be exhibited even more effectively.

[0130] Of the total surface area of ​​the above-mentioned substrate particles, the surface area covered by the above-mentioned coating layer (coverage rate) is preferably 50% or more, more preferably 70% or more, even more preferably 90% or more, still more preferably 95% or more, particularly preferably 99% or more, and most preferably 100%. When the above-mentioned coverage rate is above the above lower limit, the adhesion between the microcarrier and the cell can be further enhanced, and the effects of the present invention can be exhibited more effectively. The above-mentioned coverage rate may be 100% or less, less than 100%, or 99% or less.

[0131] The above coverage rate is determined by observing the microcarriers with an electron microscope or optical microscope and calculating the percentage of the surface area covered by the coating layer relative to the projected area of ​​the substrate particles.

[0132] The thickness of the coating layer is preferably 10 nm or more, more preferably 50 nm or more, preferably 1 μm or less, and more preferably 500 nm or less. When the thickness of the coating layer is above the lower limit and below the upper limit, the adhesion between the microcarrier and the cell can be further enhanced. Furthermore, when the thickness of the coating layer is above the lower limit and below the upper limit, the effects of the present invention can be exhibited even more effectively.

[0133] The thickness of the coating layer can be measured, for example, by observing the cross-section of the microcarrier using a scanning electron microscope (SEM). Preferably, the thickness of the coating layer is calculated by averaging the thickness of five arbitrary coating layers, and more preferably by averaging the thickness of the entire coating layer. The thickness of the coating layer is preferably determined by calculating the average thickness of the coating layer for 50 arbitrary microcarriers.

[0134] Examples of methods for obtaining the resin X having the polyvinyl alcohol derivative skeleton described above include the following methods.

[0135] A polyvinyl alcohol derivative (e.g., polyvinyl acetal resin) is reacted with a linker to obtain a reaction product in which the polyvinyl acetal resin and the linker are bonded. The obtained reaction product is reacted with a peptide to obtain a resin X having a polyvinyl alcohol derivative skeleton (polyvinyl acetal skeleton).

[0136] Examples of methods for obtaining the resin X having the poly(meth)acrylic acid ester skeleton described above include the following methods.

[0137] An acrylic resin is obtained by polymerizing monomers containing (meth)acrylic acid ester. The obtained acrylic resin is reacted with a peptide and a linker used as needed to obtain a resin X having a poly(meth)acrylic acid ester skeleton.

[0138] Examples of methods for obtaining a resin X having the above-mentioned polyvinyl alcohol derivative skeleton and the above-mentioned poly(meth)acrylic acid ester skeleton include the following methods.

[0139] A resin having a polyvinyl alcohol derivative skeleton and a poly(meth)acrylic acid ester skeleton is obtained by the following methods (i), (ii), or (iii): (i) A polyvinyl acetal resin is synthesized using polyvinyl alcohol copolymerized with an acrylic acid ester. (ii) A polyvinyl acetal resin is synthesized using polyvinyl alcohol and polyvinyl alcohol copolymerized with an acrylic acid ester. (iii) An acrylic acid ester is graft copolymerized onto the polyvinyl acetal resin. The resin obtained by the above methods (i), (ii), or (iii) is reacted with a peptide and a linker used as needed to obtain a resin X having the polyvinyl alcohol derivative skeleton and the poly(meth)acrylic acid ester skeleton.

[0140] Methods for obtaining microcarriers by arranging the coating layer on the surface of the above-mentioned substrate particles include, for example, the following methods (1) and (2).

[0141] Method (1): The resin X obtained by the above method is dissolved in a solvent to obtain a resin X-containing solution. Microcarriers can be prepared by spraying the resin X-containing solution onto substrate particles or by separating substrate particles impregnated with the resin X-containing solution to create a layer (coating layer) containing resin X on the outer surface of the substrate particles.

[0142] Method (2): A resin (resin X before peptide bonding) that does not have a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic acid ester skeleton is prepared. This resin is dissolved in a solvent to obtain a resin-containing liquid. The resin-containing liquid is sprayed onto substrate particles, or substrate particles impregnated with the resin-containing liquid are separated to obtain particles in which a layer without resin X (a layer containing a polyvinyl alcohol derivative or poly(meth)acrylic acid ester) is arranged on the outer surface of the substrate particles. The obtained particles are reacted with the polyvinyl alcohol derivative or poly(meth)acrylic acid ester contained in the layer without resin X, a peptide, and a linker used as needed, using the method described above. In this way, microcarriers can be produced on the outer surface of the substrate particles, which have a coating layer consisting of a layer without resin X and a layer containing resin X.

[0143] (More details about microcarriers) The above microcarriers are used for culturing cells.

[0144] Examples of the cells mentioned above include animal cells from humans, mice, rats, pigs, cattle, and monkeys. Other examples of the cells include somatic cells, such as stem cells, progenitor cells, and mature cells. These somatic cells may also be cancer cells.

[0145] Examples of the above-mentioned stem cells include mesenchymal stem cells (MSCs), iPS cells, ES cells, Muse cells, embryonic cancer cells, embryonic germ stem cells, and mGS cells.

[0146] Examples of the mature cells mentioned above include nerve cells, cardiomyocytes, retinal cells, and hepatocytes.

[0147] The above-mentioned microcarriers are preferably used for three-dimensional cell culture. Three-dimensional culture is a method of culturing cells with thickness in the vertical direction, in contrast to two-dimensional culture, which involves culturing cells on a flat surface such as a plate.

[0148] The above microcarrier is preferably used in serum-free culture media. Since the above microcarrier contains the above resin X, it can enhance cell adhesion even in serum-free culture media that do not contain feeder cells or adhesion proteins, and in particular, it can further enhance the initial colonization rate after cell seeding. Furthermore, since the above microcarrier contains the above resin X, the effects of the present invention can be exerted even in serum-free culture media.

[0149] Preferably, the above microcarrier contains substantially no animal-derived raw materials. By not containing animal-derived raw materials, it is possible to provide a microcarrier that is highly safe and has less variation in quality during manufacturing. "Substantially no animal-derived raw materials" means that the amount of animal-derived raw materials in the microcarrier is 3% by weight or less. Preferably, the amount of animal-derived raw materials in the above microcarrier is 1% by weight or less, and most preferably 0% by weight. In other words, it is most preferable that the above microcarrier contains no animal-derived raw materials at all.

[0150] (Methods for culturing cells) Cells can be cultured using the above-mentioned microcarriers. The cell culture method according to the present invention is a cell culture method using the above-mentioned microcarriers. Examples of the above-mentioned cells include the cells described above.

[0151] The cell culture method described above preferably includes a step of adhering the cells to the microcarrier. The cells may also be in the form of cell aggregates. These cell aggregates can be obtained by adding a cell detachment agent to a confluent culture vessel and uniformly disrupting the cells by pipetting. The cell detachment agent is not particularly limited, but ethylenediamine / phosphate buffer solution is preferred. The size of the cell aggregates is preferably 50 μm to 200 μm.

[0152] The present invention will be described in more detail below with reference to examples and comparative examples. The present invention is not limited to these examples.

[0153] The structural unit content in the obtained resin was measured by 1H-NMR (nuclear magnetic resonance spectroscopy) after dissolving the synthetic resin in DMSO-d6 (dimethyl sulfoxide).

[0154] (Example 1) (1) Preparation of base particle A 800 parts by weight of divinylbenzene (57% purity) and 200 parts by weight of styrene were mixed to obtain a mixture. 20 parts by weight of benzoyl peroxide were added to the mixture and stirred until uniformly dissolved to obtain a monomer mixture. 4000 parts by weight of a 2% aqueous solution of polyvinyl alcohol with a molecular weight of approximately 1700, dissolved in pure water, was placed in a reaction vessel. Next, the obtained monomer mixture was added to the reaction vessel and stirred for 4 hours to adjust the particle size so that the monomer droplets reached a predetermined particle size. Then, the reaction was carried out under a nitrogen atmosphere at 85°C for 9 hours to perform a polymerization reaction of the monomer droplets and obtain particles. The obtained particles were washed several times with hot water, methanol, and acetone, respectively, and then classified to obtain base particle A with an average particle size of 600 μm and a particle size CV value of 1%. Base particle A is a resin particle of divinylbenzene copolymer (indicated as DVB in the table).

[0155] (2) Preparation of polyvinyl acetal resin In a reactor equipped with a stirring device, 2700 mL of deionized water and 300 parts by weight of polyvinyl alcohol with an average degree of polymerization of 1700 and a degree of saponification of 99 mol% were added, and the mixture was heated and dissolved while stirring to obtain a solution. To the obtained solution, 35% by weight hydrochloric acid was added as a catalyst to achieve a hydrochloric acid concentration of 0.2% by weight. Next, the temperature was adjusted to 15°C, and 22 parts by weight of n-butyraldehyde was added while stirring. Then, 148 parts by weight of n-butyraldehyde was added to precipitate white particulate polyvinyl acetal resin (polyvinyl butyral resin). Fifteen minutes after precipitation, 35% by weight hydrochloric acid was added to achieve a hydrochloric acid concentration of 1.8% by weight, and the mixture was heated to 50°C and held at 50°C for 2 hours. Next, the solution was cooled and neutralized, then the polyvinyl butyral resin was washed with water and dried to obtain polyvinyl acetal resin (polyvinyl butyral resin, average degree of polymerization 1700, degree of acetalization (degree of butyralization) 70 mol%, hydroxyl group content 27 mol%, degree of acetylation 3 mol%).

[0156] (3) Formation of the linker 99 parts by weight of the obtained polyvinyl acetal resin and 1 part by weight of acrylic acid (linker) were dissolved in 300 parts by weight of THF (tetrahydrofuran), and the mixture was reacted for 20 minutes under ultraviolet irradiation in the presence of a photoradical polymerization initiator to form a linker portion by graft copolymerization of the polyvinyl acetal resin and acrylic acid.

[0157] (4) Preparation of polyvinyl acetal resin coated particles with linker portion One part by weight of polyvinyl acetal resin with a linker formed was dissolved in 19 parts by weight of butanol. One part by weight of base particle A was added to the resulting solution and stirred. The solution was then filtered, washed with pure water, and vacuum dried at 60°C for 5 hours to obtain polyvinyl acetal resin coated particles with a linker formed.

[0158] (5) Fabrication of microcarriers A linear peptide (5 amino acid residues) having the amino acid sequence Gly-Arg-Gly-Asp-Ser was prepared. 1 part by weight of this peptide and 1 part by weight of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (a bonding agent) were added to phosphate-buffered saline that did not contain either calcium or magnesium to prepare a peptide-containing solution to a final concentration of 1 mM of the peptide. 1 part by weight of polyvinyl acetal resin-coated particles with a linker moiety was added to 20 parts by weight of the resulting peptide-containing solution to dehydrate condensation of the carboxyl group of the linker moiety and the Gly amino group of the peptide. The resulting suspension was filtered, washed with pure water, and vacuum-dried at 60°C for 5 hours to obtain microcarriers. In the table, the resin X having a polyvinyl alcohol derivative skeleton (polyvinyl acetal skeleton) obtained by the above method is referred to as resin X1. Resin X1 has the amino acid sequence Gly-Arg-Gly-Asp-Ser as the peptide moiety.

[0159] (Example 2) (1) Preparation of base particle B A polymerization reaction was carried out in the same manner as in Example 1 to obtain particles. By performing a classification operation on the obtained particles, base particle B with an average particle diameter of 350 μm and a particle diameter CV value of 1% was obtained.

[0160] (2) Fabrication of microcarriers Microcarriers were prepared in the same manner as in Example 1, except that the obtained substrate particles B were used.

[0161] (Example 3) (1) Preparation of base particle C A polymerization reaction was carried out in the same manner as in Example 1 to obtain particles. By performing a classification operation on the obtained particles, base particle C with an average particle diameter of 900 μm and a particle diameter CV value of 1% was obtained.

[0162] (2) Fabrication of microcarriers Microcarriers were prepared in the same manner as in Example 1, except that the obtained substrate particles C were used.

[0163] (Example 4) (1) Preparation of base particle D A polymerization reaction was carried out in the same manner as in Example 1 to obtain particles. By performing a classification operation on the obtained particles, base particle D with an average particle diameter of 600 μm and a particle diameter CV value of 8% was obtained.

[0164] (2) Fabrication of microcarriers Microcarriers were prepared in the same manner as in Example 1, except that the obtained substrate particles D were used.

[0165] (Example 5) (1) Base material particles Base particle A was used as the base particle.

[0166] (2) Preparation of acrylic resin An acrylic monomer solution was obtained by dissolving 29 parts by weight of butyl acrylate, 3 parts by weight of 2-hydroxyethyl acrylate, and 1 part by weight of acrylic acid in 30 parts by weight of tetrahydrofuran. 1 part by weight of Irgacure 184 (BASF) was dissolved in the obtained acrylic monomer solution, and the resulting solution was coated onto a PET film. The coated object was exposed to light at a wavelength of 365 nm and an integrated light intensity of 2000 mJ / cm² using a UV conveyor device (I-Graphics "ECS301G1") at 25°C. 2 An acrylic resin solution was obtained by irradiation. The obtained acrylic resin solution was vacuum-dried at 80°C for 3 hours to obtain acrylic resin. The obtained acrylic resin contains a linker. The weight-average molecular weight of the obtained acrylic resin was approximately 100,000.

[0167] (3) Preparation of acrylic resin coated particles One part by weight of the obtained acrylic resin was dissolved in 19 parts by weight of butanol. One part by weight of base particle A was added to this solution and stirred, then filtered and washed with pure water, and vacuum dried at 60°C for 5 hours to obtain acrylic resin coated particles.

[0168] (4) Fabrication of microcarriers A microcarrier was obtained in the same manner as in Example 1, except that the obtained acrylic resin-coated particles were used. In the table, the resin X having a poly(meth)acrylate ester skeleton obtained by the above method was described as resin X2. Resin X2 has an amino acid sequence of Gly-Arg-Gly-Asp-Ser as the peptide part.

[0169] (Example 6) (1) Preparation of base material particles E A polymerization reaction was carried out in the same manner as in Example 1 to obtain particles. By performing a classification operation on the obtained particles, base material particles E having an average particle diameter of 1500 μm and a CV value of the particle diameter of 1% were obtained.

[0170] (2) Preparation of microcarrier A microcarrier was prepared in the same manner as in Example 1, except that the obtained base material particles E were used.

[0171] (Example 7) Base material particles A were used as the base material particles.

[0172] (2) Preparation of acrylic resin 10 parts by weight of dodecyl acrylate and 2.7 parts by weight of acrylic acid were dissolved in 27 parts by weight of tetrahydrofuran to obtain an acrylic monomer solution. 0.0575 parts by weight of Irgacure 184 (manufactured by BASF) was dissolved in the obtained acrylic monomer solution, and the obtained solution was applied onto a PET film. The coated material was irradiated with light having a wavelength of 365 nm and an integrated light amount of 2000 mJ / cm 2 at 25 °C using a UV conveyor device (「ECS301G1」manufactured by Eye Graphics Co., Ltd.) to obtain a (meth)acrylic copolymer solution. The obtained (meth)acrylic copolymer solution was vacuum dried at 80 °C for 3 hours to obtain an acrylic resin having a linker part.

[0173] (3) Preparation of acrylic resin-coated particles One part by weight of the obtained acrylic resin was dissolved in 19 parts by weight of butanol. One part by weight of the base particles was added to this solution and stirred. The solution was then filtered, washed with pure water, and vacuum dried at 60°C for 5 hours to obtain acrylic resin coated particles.

[0174] (4) Fabrication of microcarriers The obtained acrylic resin-coated particles were used. In addition, a cyclic peptide having the amino acid sequence Arg-Gly-Asp-Phe-Lys (5 amino acid residues, with Arg and Lys forming a cyclic skeleton, and Phe being the D-isomer) was prepared as a peptide. Using this peptide, microcarriers were obtained in the same manner as in Example 1, except that the carboxyl group in the structural unit derived from acrylic acid of the acrylic resin and the amino group of Lys in the peptide were subjected to dehydration condensation. In the table, the resin X having a poly(meth)acrylic acid ester skeleton obtained by the above method is referred to as resin X3. Resin X3 has the amino acid sequence Arg-Gly-Asp-Phe-Lys (cyclic peptide skeleton) as the peptide portion.

[0175] (Example 8) (1) Preparation of base particle F Micropearl GS-L300 (manufactured by Sekisui Chemical Co., Ltd., average particle size 300 μm, particle size CV value 7%, polyfunctional acrylic resin particles) was prepared. By performing a classification operation on these particles, base particle F with an average particle size of 300 μm and a particle size CV value of 1% was obtained. Base particle F is a resin particle of acrylic resin (indicated as ACR in the table).

[0176] (2) Fabrication of microcarriers Microcarriers were prepared in the same manner as in Example 1, except that the obtained substrate particles F were used.

[0177] (Comparative Example 1) (1) Preparation of base particle G A polymerization reaction was carried out in the same manner as in Example 1 to obtain particles. By performing a classification operation on the obtained particles, base particle G with an average particle diameter of 600 μm and a particle diameter CV value of 15% was obtained.

[0178] (2) Fabrication of microcarriers Microcarriers were prepared in the same manner as in Example 1, except that the obtained substrate particles G were used.

[0179] (Comparative Example 2) (1) Preparation of base particle H A polymerization reaction was carried out in the same manner as in Example 1 to obtain particles. By performing a classification operation on the obtained particles, base particle H with an average particle diameter of 100 μm and a particle diameter CV value of 1% was obtained.

[0180] (2) Fabrication of microcarriers Microcarriers were prepared in the same manner as in Example 1, except that the obtained substrate particles H were used.

[0181] (evaluation) (1) Average particle diameter of microcarriers and coefficient of variation (CV value) of particle diameter The obtained microcarriers were observed using a scanning electron microscope. The average particle diameter and coefficient of variation (CV) of particle diameter at the equivalent circle diameter were calculated for 50 arbitrary microcarriers.

[0182] (2) Thickness of the coating layer The cross-sections of the obtained microcarriers were observed using a scanning electron microscope. The thickness of the coating layer was measured for each of 50 randomly selected microcarriers, and the average value was defined as the thickness of the microcarrier's coating layer.

[0183] (3) The proportion of microcarriers The specific gravity of the obtained microcarriers was measured using a true hydrometer (Shimadzu Corporation's "AccuPic II") in a dry state and under an argon gas atmosphere.

[0184] (4) Water absorption rate of microcarriers The obtained microcarriers were dried in an oven at 100°C for 8 hours. 100.0 mg of these microcarriers were weighed and left for 24 hours in an environment at 37°C and 95% RH relative humidity. The weight of the microcarriers after standing was measured, and the water absorption rate of the microcarriers was calculated using the following formula.

[0185] Water absorption rate (weight %)=(W2-W1) / W1×100 W1: Weight of microcarriers before storage (mg) W2: Weight of microcarriers after standing (mg)

[0186] (5) Evaluation of cell culture 80 mg of the obtained microcarriers was weighed into one well of a 12-well plate (Corning, flat-bottomed, untreated) to prepare a culture plate.

[0187] The following liquid culture media and ROCK (Rho-binding kinase) specific inhibitors were prepared.

[0188] TeSR E8 medium (manufactured by STEM CELL) ROCK-Inhibitor (Y27632)

[0189] In a φ35mm dish, confluent h-iPS cells 253G1 and 1 mL of 0.5 mM ethylenediaminetetraacetic acid / phosphate buffer solution were added and allowed to stand at room temperature for 5 minutes. After removing the ethylenediaminetetraacetic acid / phosphate buffer solution, a cell suspension was obtained by pipetting with 1 mL of liquid medium. The obtained cell suspension was placed in a culture plate containing 1 mL of liquid medium, with a cell count of 1.0 × 10⁶. 4 The cells were sown.

[0190] Microcarriers were photographed using a phase-contrast microscope after 5 days of culture.

[0191] In any 20 microcarriers where cell adhesion was observed, the adhesion between microcarriers by cell aggregates was determined according to the following criteria.

[0192] <Criteria for determining adhesion between microcarriers> AA: Out of 20 microcarriers, fewer than 5 microcarriers show adhesion between them due to cell aggregates. A: Of the 20 microcarriers, the number of microcarriers in which adhesion between microcarriers due to cell aggregates is observed is 5 or more and less than 8. B: Of the 20 microcarriers, the number of microcarriers in which adhesion between microcarriers due to cell aggregates is observed is 8 or more and less than 10. C: Out of 20 microcarriers, adhesion between microcarriers due to cell aggregates is observed in 10 or more microcarriers.

[0193] In 20 random microcarriers where cell adhesion was observed, the uniform coverage of cells attached to the microcarriers was determined according to the following criteria.

[0194] <Criteria for determining uniform cell coverage> AA: Out of 20 microcarriers, 10 or more microcarriers have more than 90% of their surface covered by cell aggregates. A: Does not fall under "AA" above, and out of 20 microcarriers, 10 or more microcarriers have 70% or more but less than 90% of their surface covered with cell aggregates. B: Not falling under "AA" or "A" above, and of the 20 microcarriers, 10 or more microcarriers have 50% or more but less than 70% of their surface covered by cell aggregates. C: Does not fall under "AA", "A", or "B" above, and out of 20 microcarriers, 10 or more microcarriers have less than 50% of their surface covered by cell aggregates.

[0195] Details and results are shown in Tables 1 and 2 below.

[0196] [Table 1]

[0197] [Table 2] [Explanation of Symbols]

[0198] 1…Microcarriers for cell culture 2...Base material particles 3…Covering layer

Claims

1. Substrate particles and The system comprises a coating layer that covers the outer surface of the substrate particles, The coating layer comprises a resin having a polyvinyl alcohol derivative skeleton or a poly(meth)acrylic acid ester skeleton and a peptide portion. The average particle diameter is 300 μm or more. The CV value of the particle size is 10% or less. A microcarrier for cell culture with a water absorption rate of 5% by weight or less.

2. The microcarrier for cell culture according to claim 1, wherein the average particle diameter is 1000 μm or less.

3. The polyvinyl alcohol derivative skeleton is a polyvinyl acetal skeleton. The cell culture microcarrier according to claim 1 or 2, wherein the poly(meth)acrylic acid ester skeleton has structural units derived from a (meth)acrylate compound (A) represented by the following formula (A1) or the following formula (A2). 【Chemistry 1】 In the above formula (A1), R represents a hydrocarbon group having 2 to 18 carbon atoms. 【Chemistry 2】 In the above formula (A2), R represents a hydrocarbon group having 2 to 18 carbon atoms.

4. The resin has the polyvinyl acetal skeleton, The microcarrier for cell culture according to claim 3, wherein the polyvinyl acetal skeleton is a polyvinyl butyral skeleton.

5. The microcarrier for cell culture according to any one of claims 1 to 4, wherein the thickness of the coating layer is 10 nm or more and 1 μm or less.

6. A microcarrier for cell culture according to any one of claims 1 to 5, wherein the average particle diameter is 400 μm or more.

7. Specific gravity is 1 g / cm³ 3 1.2g / cm or more 3 The following is a microcarrier for cell culture according to any one of claims 1 to 6.

8. The microcarrier for cell culture according to any one of claims 1 to 7, wherein the base material particles are resin particles.

9. The microcarrier for cell culture according to any one of claims 1 to 8, wherein the base particles include a polymer of a monomer having an ethylenically unsaturated group.

10. The microcarrier for cell culture according to claim 9, wherein the polymer of the monomer having an ethylenically unsaturated group is an acrylic resin, a divinylbenzene polymer, or a divinylbenzene copolymer.

11. The microcarrier for cell culture according to claim 9 or 10, wherein the polymer of the monomer having an ethylenically unsaturated group is a divinylbenzene polymer or a divinylbenzene copolymer.

12. The cell culture microcarrier according to any one of claims 1 to 11, wherein the peptide portion has a cell-adherent amino acid sequence.

13. A method for culturing cells, comprising the step of adhering cells to a cell culture microcarrier according to any one of claims 1 to 12.